Skip to main content
Caplight Logo









Convexia

Convexia

Private
San Francisco, CaliforniaHealthcare & Life Scienceshttps://www.convexia.bio/

Last Round

Seed

Jul 25, 2025

Total Funding Raised

$1M

Momentum

Top 25%

of companies Caplight tracks

Company Overview

Convexia is a healthcare company that provides an AI-driven platform for pharmaceutical drug discovery, asset sourcing, and clinical development.

Sector

Healthcare & Life Sciences

Verticals

Drug Discovery, Biotechnology, Medical AI, Clinical Trials

Business Model

B2B

Customer Profile

Subscription SaaS, Services & Consulting

AI Layer

Application

Keywords

ai drug discoveryautonomous ai agentsdrug discovery aidrug developmentai pharmapharma diligencedrug discovery agentsclinical trial simulationagentic aiin silico assessmentdrug asset sourcingbiotech softwareai agent platformai drug pipeline

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Convexia Comparables

Compare Convexia with similar companies based on industry and business-model similarity.

Convexia comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Perceptic
87%
One Zyme
85%
Optic
81%

Convexia Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
SeedJul 25, 2025

Key People

Founding team and executive leadership

Ayaan Parikh

Co-Founder & CEO

Founding Team

Convexia Investors

Notable investors and investment history

Convexia investors
InvestorRounds
Y CombinatorSeed

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jul 20, 2026

    Grew 133% QoQ from 3 to 7 employees.

  • Mar 3, 2026

    Monthly visitors grew 71% MoM, from 3.4K to 5.9K.

Convexia Filings

Explore SEC and related filing metadata, where available.

Convexia filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Convexia's valuation, stock price, and market status.

Is Convexia a public or private company?

Convexia is a private company.

What is the current stock price of Convexia?

Convexia is a private company with no public stock price. No recent secondary market data is available.

How much is Convexia worth (valuation)?

Valuation information for Convexia is not publicly available.

Can I buy Convexia stock?

Convexia shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Convexia's last funding round?

Convexia's most recent funding round was Seed on July 25, 2025.

Who are the main investors in Convexia?

Key investors in Convexia include Y Combinator.

Will Convexia IPO soon?

No public IPO plans have been announced for Convexia.

How can I track Convexia secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Convexia's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersSan Francisco, California
Employee Range9
Year Founded2025
Last FundingJul 25, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?